Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Johnson &amp; Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Closing Bell

Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson and Johnson's consumer help spin off Ken View debuted on the floor of the New York Stock Exchange earlier today in the biggest ipo since electric vehicle vehicle company Ruben back in 2021 can view shares opening up 16% at $25.53 a piece. The new company is home to some of the most recognizable brands in this space like Band aid, Tylenol, Listerine and Neutrogena just to name a few. Joining me now is Ken Ceo at T Bo Bo. Congratulations. Thank you. Thank you for having me. A lot of cheers down here on happy faces on the floor of the New York Stock Exchange. A pretty impressive debut. Is this what you would have expected? It's a big day for Ken View and for all 22,000 team members around the world, we are bringing to life today with Ken View listing, the largest Pure Play consumer health company in the world, $15 billion in revenues presence in 165 countries brands that you are familiar with that are in the houses around the world and today millions of consumers wake up with a can brand in their home, think about nitrogen Listerine A aid and so many others that you are familiar with. So we are excited about today and about what lies ahead. Certainly cheering the IPO. Even amid a down overall stock stock market today, can you share is rising now as a new publicly traded company? How are you going to grow the business? Yeah, we are doing this from a position of strength. We have an incredible portfolio of iconic brands that are grounded in science recommended by health care professionals around the world. And so we are excited about the opportunity to grow these brands in categories moving forward. We have so many opportunities ahead of us. There is no limit for you to take better care of your health. There is no limit for K to invent new products and solutions to help you do that. So it's a summer season right now. Unfortunately, many Americans don't use sunscreen on a regular basis. So our Neutrogena teams as an example did step up to the challenge and launched a new product called Neutrogena Invisible Defense. That is a sunscreen that doesn't leave any residue on your, on your skin. And we believe that it will give Americans another opportunity to revisit their decisions and start using sunscreen and have a great service thanks to Neutrogena. So it sounds like that is one product innovation for Neutrogena that we expect here in the pipeline. What other product innovations. Can consumers expect? We have a great pipeline of innovation. I give you an example of a product innovation, but we also invest in digital companions that allow consumers to take better care of their health. It's allergy season, for example. And we are a market leader with Zoch, but we have developed a companion app that you put on your phone and allows you to better manage your allergy symptoms depending on where you live in the United States. That's an example of how at can you will help you take better care of your health. Johnson and Johnson, your former parent company is still a majority shareholder in this new public publicly traded company, more than 80% ownership of the stock, but they do have the ability to sell that before the end of the year. How is your company preparing for that? Amid these market conditions has been very clear that they intend to complete a separation in 2023 we are on track with this plan. This listing day to day is the first step. We are very excited about it. We are doing it from a position of strength. The business is extremely healthy. So we are very confident, very confident. All right, you heard it there from Tebogo CEO of KVI on a very impressive market debut down here on the stock exchange, the biggest IPO that we've seen since the end of 2021. Thank you. Thank you.